432 patents currently held
19 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2031. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2031
Next term end
351
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Sep 2037 · High confidence
Also notable
Ends Nov 2042 · High confidence
Also notable
Ends Oct 2041 · High confidence
DNA Polymerase Mutants with Increased Processivity of DNA Synthesis
US 10,704,031
The earliest of the three still in force, granted 2020 and renewed since. Its term ends first, in 2037.
Method for Preparing High-load Oral Paclitaxel Capsule for Slow Release in Colon
US 11,771,676
A family of 65 related applications built on the 2023 grant. Protection runs to 2042.
Flat-Knitted Three-Dimensional Fabric with Internal Support Structure, and Method for Preparing Same
US 11,828,008
A family of 39 related applications built on the 2023 grant. Protection runs to 2041.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 4 fees due Nov 23, 2026
- 7 fees due Dec 4 to 27, 2026 · next Dec 4
- 7 fees due Jan 2 to 16, 2027 · next Jan 2
- 11 fees due Feb 8 to 27, 2027 · next Feb 8
- 6 fees due Mar 10 to 26, 2027 · next Mar 10
- 12 fees due Apr 3 to 30, 2027 · next Apr 3
- 7 fees due May 5 to 28, 2027 · next May 5
- 11 fees due Jun 3 to 30, 2027 · next Jun 3
- 6 fees due Jul 2 to 23, 2027 · next Jul 2
- 5 fees due Aug 6 to 27, 2027 · next Aug 6
- 5 fees due Sep 8 to 30, 2027 · next Sep 8
- 20 fees due Oct 2 to 30, 2027 · next Oct 2
- 9 fees due Nov 3 to 14, 2027 · next Nov 3
Recent changes
- 8 of the patents on this record were granted since Aug 19, 2026
- 9 terms have ended since Aug 19, 2026
What they patent
The 5 largest of its 351 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Method of Preparing Electric and Temperature Dual-control Bi-stable Color-changing Dyes and Microcapsules | 34 in force | to May 2044 |
| Bionic Digestive Tract as well as Preparation Method and Application Thereof | 26 in force | to Jan 2045 |
| Hybridoma cell line that secrets cyproheptadine monoclonal antibodies and preparation method thereof | 17 in force | to Apr 2044 |
| Promoter and Use Thereof | 3 in force | to Nov 2036 |
| Alginate Lyase and Application thereof | 2 in force | to Aug 2041 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,512,700 | Antibody Protective Agent and Methods of Using Same In force · High confidence | In force | High confidence | |
| US 9,649,347 | Protective Effects and Application of a Lactobacillus Rhamnosus on the Alleviation of Chronic Alcoholic Liver Injury In force · Medium confidence | In force | Medium confidence | |
| US 9,109,212 | Method for Enhancing Extracellular Secretion of Recombinant Proteins in Escherichia Coli by Co-Expressing Thermobifida Fusca Cutinase In force · High confidence | In force | High confidence | |
| US 9,328,363 | Genetically Engineered Yarrowia Lipolytica with Enhanced Extracellular Secretion of a-ketoglutarate In force · High confidence | In force | High confidence | |
| US 10,167,456 | Bifunctional Lipase Mutant and Methods of Using Same In force · High confidence | In force | High confidence | |
| US 9,982,269 | Mortierella Alpine Uracil Auxotroph with URA5 Gene Knocked Out Through Homologous Recombination, and Construction Method Thereof In force · Medium confidence | In force | Medium confidence | |
| US 9,279,111 | Novel Leech Hyaluronidase and Its Application In force · High confidence | In force | High confidence | |
| US 9,149,064 | Method of Producing Nanofibrillar Cellulose with High Absorptivity to Fat and Cholate In force · High confidence | In force | High confidence | |
| US 9,237,756 | Method for Preparing and Conditioning Granular Burdock Roots Through Combined Uniform Drying By Using Radio Frequency Pretreatment and Microwave Pulse Spouting In force · High confidence | In force | High confidence | |
| US 9,238,742 | Method of preparing UV-curable Inkjet Pigment Ink for Textile Printing In force · High confidence | In force | High confidence |
Also on record, not counted in the 432: 19 patents in force now held by others · 114 patents ended · 85 applications pending · 100 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.